Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Jacene

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
AJR. American Journal of Roentgenology|September 25, 2013
Imatinib and beyond in gastrointestinal stromal tumors: A radiologist's perspectiveSree Harsha Tirumani, Jyothi P Jagannathan, Katherine M Krajewski, et al.
Oncology and Therapy|April 5, 2026
Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic ExpertsDésirée Deandreis, Heather Jacene, Patrick Therasse, et al.
Clinical Genitourinary Cancer|February 25, 2025
Activity of 177Lu-PSMA-617 in Patients With Advanced Prostate Cancer and Brain MetastasesNarmeen S Rashid, Avina Rami, Min Lang, et al.
Medical Physics|March 19, 2009
Evaluation of quantitative imaging methods for organ activity and residence time estimation using a population of phantoms having realistic variations in anatomy and uptakeBin He, Yong Du, W Paul Segars, et al.
Clinical Genitourinary Cancer|March 27, 2026
Monitoring of Disease in Patients Receiving <sup>177</sup>LU-PSMA-617 Therapy in Routine PracticeNarmeen S Rashid, Caiwei Zhong, Wanling Xie, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2021
Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the UnknownsRichard L Wahl, George Sgouros, Amir Iravani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2017
Quantitation of Cancer Treatment Response by <sup>18</sup>F-FDG PET/CT: Multicenter Assessment of Measurement VariabilityJoo Hyun O, Heather Jacene, Brandon Luber, et al.
Molecular Imaging and Biology|November 1, 2016
Initial Experience with Tositumomab and I-131-Labeled Tositumomab for Treatment of Relapsed/Refractory Hodgkin LymphomaHeather Jacene, John Crandall, Yvette L Kasamon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2021
Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current PracticeNeeta Pandit-Taskar, Amir Iravani, Dan Lee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 11, 2025
Summary: SNMMI/ACNM Procedure Standard for Posttreatment Imaging of <sup>177</sup>Lu-Based RadiopharmaceuticalsCarlos Uribe, Amir Iravani, Bital Savir-Baruch, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
AJR. American Journal of Roentgenology|September 25, 2013
Imatinib and beyond in gastrointestinal stromal tumors: A radiologist's perspectiveSree Harsha Tirumani, Jyothi P Jagannathan, Katherine M Krajewski, et al.
Oncology and Therapy|April 5, 2026
Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic ExpertsDésirée Deandreis, Heather Jacene, Patrick Therasse, et al.
Clinical Genitourinary Cancer|February 25, 2025
Activity of 177Lu-PSMA-617 in Patients With Advanced Prostate Cancer and Brain MetastasesNarmeen S Rashid, Avina Rami, Min Lang, et al.
Medical Physics|March 19, 2009
Evaluation of quantitative imaging methods for organ activity and residence time estimation using a population of phantoms having realistic variations in anatomy and uptakeBin He, Yong Du, W Paul Segars, et al.
Clinical Genitourinary Cancer|March 27, 2026
Monitoring of Disease in Patients Receiving <sup>177</sup>LU-PSMA-617 Therapy in Routine PracticeNarmeen S Rashid, Caiwei Zhong, Wanling Xie, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2021
Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the UnknownsRichard L Wahl, George Sgouros, Amir Iravani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2017
Quantitation of Cancer Treatment Response by <sup>18</sup>F-FDG PET/CT: Multicenter Assessment of Measurement VariabilityJoo Hyun O, Heather Jacene, Brandon Luber, et al.
Molecular Imaging and Biology|November 1, 2016
Initial Experience with Tositumomab and I-131-Labeled Tositumomab for Treatment of Relapsed/Refractory Hodgkin LymphomaHeather Jacene, John Crandall, Yvette L Kasamon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2021
Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current PracticeNeeta Pandit-Taskar, Amir Iravani, Dan Lee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 11, 2025
Summary: SNMMI/ACNM Procedure Standard for Posttreatment Imaging of <sup>177</sup>Lu-Based RadiopharmaceuticalsCarlos Uribe, Amir Iravani, Bital Savir-Baruch, et al.
Pageof 7